MEA Bioreactors Market Size & Growth (2019-2024):
The size of the Bioreactors Market in the Middle East & Africa is valued at USD 93.07 Million in 2019 and estimated to be growing at a CAGR of 7%, to reach USD 130.57 Million by 2024 during the forecast period 2019-2024.
A bioreactor is a manufacturing device that supports a biologically active environment. It is a vessel in which a chemical process is taken place which involves organisms or biochemically active substances derived from such organisms. These devices are being developed for use in tissue engineering or biochemical engineering. Rising Chronic disease prevalence and increasing biopharmaceutical investments will propel the growth of the market.
Rising chronic diseases prevalence, increase in the incidence of lifestyle diseases like diabetes and cancer, rising biopharmaceutical investments, increasing demand for therapeutically active vaccines, product innovation and favorable government initiatives to develop healthcare infrastructure are the factors driving the growth of the market. Growing personalized medicine market and increasing popularity for them and increasing the popularity of single-use bioreactors among the biopharmaceutical companies will also boost the market.
Nevertheless, regulatory issues regarding single-use bioreactors, limited storage and vulnerability to leaching may hinder the growth of the market. Likewise, large scale disposal of plastic derivatives is an environmental concern restraining the growth.
This research report segmented and sub-segmented into the following categories:
Noteworthy companies operating in the MEA Bioreactors Market Profiled in the Report are Sartorius AG, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Danaher Corporation, Eppendorf AG, and major Engineering, Procurement and Construction (EPC) players included in this report are Amec Foster Wheeler plc., Fluor Corporation, Jacobs Engineering Group Inc., M+W Group, PM Group, and Technip S.A.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Material
5.1.1 Introduction
5.1.2 Glass
5.1.3 Stainless-Steel
5.1.4 Single-Use
5.1.5 Y-o-Y Growth Analysis, By Material
5.1.6 Market Attractiveness Analysis, By Material
5.1.7 Market Share Analysis, By Material
5.2 Scale
5.2.1 Introduction
5.2.2 5L-20L
5.2.3 20L-200L
5.2.4 200L-2000L
5.2.5 Over 1500L
5.2.6 Y-o-Y Growth Analysis, By Scale
5.2.7 Market Attractiveness Analysis, By Scale
5.2.8 Market Share Analysis, By Scale
5.3 Production Size
5.3.1 Introduction
5.3.2 Lab-Scale
5.3.3 Pilot-Scale
5.3.4 Full-Scale
5.3.5 Y-o-Y Growth Analysis, By Production Size
5.3.6 Market Attractiveness Analysis, By Production Size
5.3.7 Market Share Analysis, By Production Size
5.4 Control Type
5.4.1 Introduction
5.4.2 Manual
5.4.3 Automated (MFCs)
5.4.4 Y-o-Y Growth Analysis, By Control Type
5.4.5 Market Attractiveness Analysis, By Control Type
5.4.6 Market Share Analysis, By Control Type
5.5 End Users
5.5.1 Introduction
5.5.2 R&D Departments
5.5.3 R&D Institutes
5.5.4 Contract Research Organizations (CROs)
5.5.5 Biopharmaceutical Companies
5.5.6 Biopharmaceutical Manufacturers
5.5.7 Contract Manufacturing Organizations (CMOs)
5.5.8 Y-o-Y Growth Analysis, By End Users
5.5.9 Market Attractiveness Analysis, By End Users
5.5.10 Market Share Analysis, By End Users
5.6 Suppliers
5.6.1 Introduction
5.6.2 Original Electronics Manufacturers (OEMs)
5.6.3 System Integrators
5.6.4 Engineering Procurement and Construction (EPCs)
5.6.5 Y-o-Y Growth Analysis, By Suppliers
5.6.6 Market Attractiveness Analysis, By Suppliers
5.6.7 Market Share Analysis, By Suppliers
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Material
6.1.3.3 By Scale
6.1.3.4 By Production Size
6.1.3.5 By Control Type
6.1.3.6 By End Users
6.1.3.7 By Suppliers
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Material
6.1.4.3 By Scale
6.1.4.4 By Production Size
6.1.4.5 By Control Type
6.1.4.6 By End Users
6.1.4.7 By Suppliers
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Material
6.1.5.3 By Scale
6.1.5.4 By Production Size
6.1.5.5 By Control Type
6.1.5.6 By End Users
6.1.5.7 By Suppliers
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Sartorius AG
8.1.1 Overview
8.1.2 Material Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Thermo Fisher Scientific
8.3 Merck KGaA
8.4 GE Healthcare
8.5 Danaher Corporation
8.6 Eppendorf AG
8.7 Amec Foster Wheeler plc
8.8 Fluor Corporation
8.9 Jacobs Engineering Group
8.10 M+W Group
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Related Reports
Aug 2019
Download Sample
